journal article·2019-01

3D-printed flexible polymer stents for potential applications in inoperable esophageal malignancies

Maohua Lin, Negar Firoozi, Chi-Tay Tsai, Michael B. Wallace, Yunqing Kang

Acta Biomaterialia· Volume 83
Publisher page

Abstract

Palliation therapy for dysphagia using esophageal stents is the current treatment of choice for those patients with inoperable esophageal malignancies. However, the metallic and plastic stents currently used in the clinical setting may cause complications, such as tumor ingrowth and stent migration into the stomach. To effectively reduce/overcome these complications, we designed a tubular, flexible polymer stent with spirals. The parameters of the spirals were computationally optimized by using a finite element analysis. The designed polymer stents with optimized spirals were then printed by a 3D printing technique. 3D-printed tubular polymer stents without spirals served as controls. The self-expansion and anti-migration properties of the printed stent were characterized in an ex vivo normal porcine esophagus. The biodegradability test of the stent was performed in a neutral buffer and acidic gastric buffer. The cytotoxicity of the new stent was examined through the viability test of human esophagus epithelial cells. Results showed the self-expansion force of the 3D-printed polymer stent with spirals was higher than the stent without spirals. The anti-migration force of the 3D-printed stent with spirals was significantly higher than that of the stent without spirals. Furthermore, the stent with spirals significantly decreased the migration distance compared to the non-spiral 3D-printed polymer stent. Degradation study showed that the polymer materials started to degrade after six weeks and the compressive strength of the stent was not significantly decreased with time. In vitro cell viability results further indicated that the polymer stent does not have any cytotoxicity. Together, these results showed that the 3D-printed stent with spirals has potential applications in the treatment of inoperable esophageal malignancies. STATEMENT OF SIGNIFICANCE: In this study, we developed a new 3D-printed flexible tubular polymeric stent with spirals. The mechanical properties of the 3D-printed polymer stent are modulated by changing the ratios of PLA to TPU. The stent is flexible enough to be compressed in a clinically available stent delivery system, and can self-expand after it is released. The self-expansion force of the stent with spirals is higher than that of non-spiral stents. The spirals on the outside of the stent significantly increased the anti-migration force compared to non-spiral stents in an ex vivo normal pig esophagus. Together, the 3D-printed stent with spirals will bring promising potential in the treatment of inoperable esophagus malignancies or benign strictures.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Esophageal and GI Pathology · Tracheal and airway disorders · Dysphagia Assessment and Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Recent advancements in esophageal cancer treatment in Japan10.1002/ags3.12174 ↗
2. Development of a prediction model of adverse events after stent placement for esophageal cancer10.1016/j.gie.2015.08.047 ↗
3. Self-expanding plastic stents in treatment of benign esophageal conditions10.1016/j.gie.2007.04.031 ↗
4. Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent10.1016/j.athoracsur.2004.07.006 ↗
5. Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures10.1016/S0016-5107(04)01882-6 ↗
6. Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study10.1111/j.1572-0241.2008.02177.x ↗
7. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial10.1111/j.1572-0241.2007.01542.x ↗
8. Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: a cost-effectiveness analysis10.1155/2015/743417 ↗
9. A comprehensive review of esophageal stents
10. The evolution and current utility of esophageal stent placement for the treatment of acute esophageal perforation10.1016/j.thorsurg.2016.04.012 ↗
11. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract10.1056/NEJM200105313442206 ↗
12. Fully covered self-expandable metal stents for benign esophageal disease: a multicenter retrospective case series of 31 patients10.1016/j.gie.2011.02.024 ↗
13. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas10.1016/S1051-0443(07)61886-7 ↗
14. Perforation of the esophagus secondary to insertion of covered Wallstent endoprostheses10.1007/s002709900196 ↗
15. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer10.1016/j.gie.2006.12.018 ↗
16. Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosis10.3748/wjg.v13.i29.3977 ↗
17. Endoscopic submucosal dissection combined with the placement of biodegradable stents for recurrent esophageal cancer after chemoradiotherapy10.1007/s12029-011-9283-z ↗
18. Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial10.1159/000100504 ↗
19. A comparison of temporary self-expanding plastic and biodegradable stents for refractory benign esophageal strictures10.1016/j.cgh.2011.04.006 ↗
20. The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease10.1007/s00464-012-2192-9 ↗
21. Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures10.1007/s00330-009-1662-5 ↗
22. Biodegradable stents for the treatment of refractory or recurrent benign esophageal stenosis10.1080/17434440.2016.1184967 ↗
23. Otaibi, Endoscopic biodegradable stents as a rescue treatment in the management of post bariatric surgery leaks: a case series10.1055/a-0600-9562 ↗
24. The role of biodegradable stents in the management of benign and malignant oesophageal strictures: a cohort study10.1016/j.surge.2015.01.002 ↗
25. Plastic and biodegradable stents for complex and refractory benign esophageal strictures10.5946/ce.2014.47.4.295 ↗
26. Polydimethylsiloxane/polyether-mixed macrodiol-based polyurethane elastomers: biostability10.1016/S0142-9612(99)00271-9 ↗
27. The effect of sterilisation on a poly (dimethylsiloxane)/poly (hexamethylene oxide) mixed macrodiol-based polyurethane elastomer10.1016/j.biomaterials.2006.04.017 ↗
28. Regeneration of bicortical defects in the iliac crest of estrogen-deficient sheep, using new biodegradable polyurethane bone graft substitutes10.1002/jbm.a.30669 ↗
29. Production of porous polylactic acid monoliths via nonsolvent induced phase separation10.1016/j.polymer.2014.10.063 ↗
30. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir10.1016/j.jconrel.2012.08.033 ↗
31. Mechanical properties, morphology, and crystallization behavior of blends of poly(L-lactide) with poly(butylene succinate-co-L-lactate) and poly(butylene succinate)10.1016/j.polymer.2006.03.065 ↗
32. Toughening of polylactide by melt blending with a biodegradable poly (ether) urethane elastomer10.1002/mabi.200700027 ↗
33. Frequency content of esophageal peristaltic pressure
34. High amplitude, peristaltic esophageal contractions associated with chest pain and/or dysphagia10.1016/0016-5085(79)90008-8 ↗
35. Hoehn · 2010
36. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions10.1016/j.jconrel.2012.06.006 ↗
37. Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates10.1016/j.biomaterials.2007.12.046 ↗
38. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications10.1016/j.biomaterials.2004.10.018 ↗
39. Fabrication and surface modification of macroporous poly (L-lactic acid) and poly (L-lactic-co-glycolic acid)(70/30) cell scaffolds for human skin fibroblast cell culture10.1002/jbm.10318 ↗
40. Synthesis of poly (ε-caprolactone) based polyurethane semi-interpenetrating polymer networks as scaffolds for skin tissue regeneration10.1080/00914037.2016.1276059 ↗
41. In vitro evaluation of the radial and axial force of self-expanding esophageal stents10.1055/s-0033-1344985 ↗
42. Current applications of endoscopic suturing10.4253/wjge.v7.i8.777 ↗
43. Endoscopic modalities for upper gastrointestinal leaks, fistulae and perforations10.1111/ans.13355 ↗
44. Role of stenting in gastrointestinal benign and malignant diseases10.4253/wjge.v7.i5.460 ↗
45. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma10.1136/gut.52.7.922 ↗
46. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study10.1067/mge.2001.116879 ↗
47. Fernandez-Pacheco, Esophageal obstruction due to a collapsed biodegradable esophageal stent10.1055/s-0030-1256324 ↗
48. Effect of a paclitaxel-eluting metallic stent on rabbit esophagus10.3892/etm.2016.3708 ↗
49. The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model10.1371/journal.pone.0173262 ↗
50. Role of esophageal metal stents placement and combination therapy in inoperable esophageal carcinoma: a systematic review and meta-analysis10.1007/s10620-018-4957-z ↗
51. Fracture of Memotherm metallic stents in the biliary tract10.1007/s002709910008 ↗
52. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux10.1148/radiol.2252011763 ↗
53. Self-expandable metallic stent placement for the palliation of esophageal cancer10.3346/jkms.2017.32.7.1062 ↗